Study: Early initiation of prophylactic anticoagulation in hospitalised COVID-19 patients

United States // 12 February, 2021

A study published in the BMJ investigated the possible effects of early initiation of prophylactic anticoagulation on risk of death among hospitalised COVID-19 patients in the United States. Results have shown that early initiation of prophylactic anticoagulation was "associated with a decreased risk of 30 day mortality and no increased risk of serious bleeding events." These findings suggests the use of prophylactic anticoagulation as treatment for hospitalised COVID-19 patients.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5